Growth Metrics

Castle Biosciences (CSTL) Depreciation and Depletion (2018 - 2026)

Castle Biosciences' Depreciation and Depletion history spans 8 years, with the latest figure at $1.5 million for Q4 2025.

  • On a quarterly basis, Depreciation and Depletion rose 5.11% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.9 million, a 21.3% increase, with the full-year FY2025 number at $5.9 million, up 21.3% from a year prior.
  • Depreciation and Depletion hit $1.5 million in Q4 2025 for Castle Biosciences, down from $1.5 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for CSTL hit a ceiling of $1.5 million in Q3 2025 and a floor of $233000.0 in Q1 2021.
  • Historically, Depreciation and Depletion has averaged $893350.0 across 5 years, with a median of $847000.0 in 2023.
  • Biggest five-year swings in Depreciation and Depletion: soared 270.59% in 2021 and later grew 5.11% in 2025.
  • Tracing CSTL's Depreciation and Depletion over 5 years: stood at $442000.0 in 2021, then surged by 41.86% to $627000.0 in 2022, then soared by 51.99% to $953000.0 in 2023, then skyrocketed by 49.84% to $1.4 million in 2024, then increased by 5.11% to $1.5 million in 2025.
  • Business Quant data shows Depreciation and Depletion for CSTL at $1.5 million in Q4 2025, $1.5 million in Q3 2025, and $1.5 million in Q2 2025.